Senti Biosciences (SNTI) Interest & Investment Income (2021 - 2025)
Senti Biosciences' quarterly Interest & Investment Income came in at $97000.0 in Q4 2025, down 57.83% year-on-year from $230000.0 in Q4 2024, and down 41.57% quarter-over-quarter from $166000.0 in Q3 2025.
Senti Biosciences has reported Interest & Investment Income for 5 years, with the latest figure at $97000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 57.83% year-over-year to $97000.0; the trailing twelve-month figure through Dec 2025 stood at $927000.0 (down 2.11% YoY), and the FY2025 full-year result was $927000.0, down 2.22% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $97000.0, down from $166000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.1 million in Q4 2022, with the low at $2000.0 in Q2 2021.
- Average Interest & Investment Income over 5 years is $339725.5, with a median of $236000.0 recorded in 2024.
- Year-over-year, Interest & Investment Income surged 26425.0% in 2023 and tumbled 74.27% in 2024.
- Tracing SNTI's Interest & Investment Income over 5 years: stood at $8784.0 in 2021, then surged by 12741.53% to $1.1 million in 2022, then tumbled by 62.23% to $426000.0 in 2023, then tumbled by 46.01% to $230000.0 in 2024, then plunged by 57.83% to $97000.0 in 2025.
- The last three Interest & Investment Income figures came in at $97000.0 (Q4 2025), $166000.0 (Q3 2025), and $270000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 331,000.00 |
| Dec 31, 2023 | 426,000.00 |
| Sep 30, 2023 | 583,000.00 |
| Jun 30, 2023 | 794,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 542,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 8,784.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 2,000.00 |